Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma
Makoto Chuma(Yokohama City University Medical Center), Shin Maeda(University of Tokyo Hospital), Hidenori Toyoda(Ogaki Municipal Hospital), Makoto Sugimori(Yokohama City University Medical Center), Kazushi Numata(Yokohama City University Medical Center), Satoshi Yasuda(Tohoku University), Yusuke Mishima(Tokai University), Atsushi Hiraoka(Ehime Prefectural Central Hospital), Takashi Kumada(Gifu Kyoritsu University), Tomomi Okubo(Nippon Medical School), Shuichiro Iwasaki(Kitasato University), Chika Kusano(Kitasato University), Kota Tsuruya(Tokai University), Toshifumi Tada(Himeji Red Cross Hospital), Akito Nozaki(Yokohama City University Medical Center), Tatehiro Kagawa(Tokai University), Masanori Atsukawa(Nippon Medical School), Yuichi Koshiyama(Ogaki Municipal Hospital), Haruki Uojima(National Center for Global Health and Medicine), Yuki Miura(Japanese Red Cross Hadano Hospital), Manabu Morimoto(Kanagawa Prefectural Hospital Organization), Chikako Tokoro, Norio Itokawa(Chiba Hokusou Hospital), Yoshitake Arase(Tokai University), Hisashi Hidaka(Kitasato University)
Cited by 11
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586